PAR paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6

  1. 18,515 Posts.
    lightbulb Created with Sketch. 5269
    Agreed, however there’s plenty of cash to get them into the second half (plenty of time to make a deal) and no shortage of approaching catalysts, with the P3 trial kicking off following ethics approval in a few weeks.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
39.0¢
Change
-0.010(2.50%)
Mkt cap ! $154.9M
Open High Low Value Volume
39.0¢ 40.0¢ 38.5¢ $221.5K 566.5K

Buyers (Bids)

No. Vol. Price($)
1 16597 39.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 97867 13
View Market Depth
Last trade - 14.56pm 30/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.